Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026)

Cresco Labs filings provide 8 years of Other Non Operating Income readings, the most recent being $960000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 176.66% to $960000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$10.6 million, a 83.06% increase, with the full-year FY2025 number at -$11.2 million, up 82.38% from a year prior.
  • Other Non Operating Income hit $960000.0 in Q1 2026 for Cresco Labs, down from $2.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $14.8 million in Q3 2022 to a low of -$59.5 million in Q2 2024.
  • Median Other Non Operating Income over the past 5 years was $347000.0 (2025), compared with a mean of -$2.9 million.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 1489.86% in 2023 and later crashed 267140.0% in 2025.
  • Cresco Labs' Other Non Operating Income stood at $2.5 million in 2022, then plummeted by 101.98% to -$50000.0 in 2023, then crashed by 6444.0% to -$3.3 million in 2024, then surged by 181.42% to $2.7 million in 2025, then crashed by 63.96% to $960000.0 in 2026.
  • The last three reported values for Other Non Operating Income were $960000.0 (Q1 2026), $2.7 million (Q4 2025), and -$13.4 million (Q3 2025) per Business Quant data.